Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Marijuana Regulation topic
No spam. Unsubscribe anytime.
Colorado House keeps daily marijuana purchase limit after heated debate
Summary
The Colorado House rejected an amendment that would have raised the daily retail purchase limit for adult-use marijuana and later passed House Bill 12‑09 as amended; the floor debate focused on youth diversion, product potency and alignment of possession and sales limits.
The Colorado House voted to adopt House Bill 12‑09 as amended on March 19, 2025, after extended debate over whether to increase the statutory daily retail purchase limit for adult‑use marijuana.
Supporters of retaining the current limit said the cap is a public‑health protection that reduces the risk high‑potency products are diverted to underage users. Representative Dylan Brown, a member of the Health and Human Services committee, urged colleagues to preserve the existing restriction, saying the measure “helps to maintain an important public health protection” and that raising the limit “will allow more high potency products to end up in the hands of kids.”
The bill overall seeks to streamline and modernize several regulatory requirements for marijuana licensees, including campaign‑style procedural and administrative changes to make licensing more digital and reduce compliance burdens. Sponsors argued the measure will reduce regulatory friction for businesses and better align cannabis rules with other regulated products.
Opponents warned that increasing the daily sales cap would enlarge volumes available for diversion and black‑market resale. Representative Hertzick said that doubling the sales limit would dramatically expand the amount of product legally purchasable at one visit and warned of potential increases in crime and youth access. Representative Seguin described local experience in Cortez where out‑of‑state purchases were resold across state lines.
Other lawmakers criticized the statutory mismatch between the current possession limit and the daily sales cap, arguing the limits should be aligned. Representative Linstead described the inconsistency as “a strange, unique circumstance” and said aligning sales and possession limits would remove an unenforceable rule that “isn't providing any legitimate public health purpose.”
The House rejected amendment L015, offered by Representatives Brown and Hartzuck, which would have kept the existing one‑ounce daily sales cap; the noes prevailed on that amendment in the Finance Committee context but the Hartzuck floor amendment to the Committee of the Whole was later adopted. Following final floor action the Committee of the Whole report as amended was adopted and the bill passed.
Votes and next steps: the House adopted the Committee of the Whole report related to HB 12‑09 by a recorded count of 42 yeas, 22 nays, and 1 excused; the bill was passed as amended and will proceed to the next legislative stage.
The debate highlighted a split between lawmakers prioritizing public‑health concerns about youth access and high‑potency products and those emphasizing regulatory consistency and relief for licensed businesses. Additional negotiation over potency‑specific limits and other technical fixes was discussed as a possible way to find compromise in later stages.
